Free Trial
→ New Chip takes minutes, not days (From Eagle Publishing) (Ad)tc pixel
OTCMKTS:VSQTF

Victory Square Technologies Q1 2025 Earnings Results & Report

Victory Square Technologies logo
$0.37 -0.01 (-1.48%)
As of 10/9/2026 03:51 PM Eastern

Victory Square Technologies reported Q1 2025 earnings on July 8, 2025. The company reported EPS of -$0.02, while revenue was $3.16 million.

Research:ProfileEarnings History

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
After Market Closes

Victory Square Technologies EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Victory Square Technologies Revenue Results

Actual Revenue
$3.16 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Victory Square Technologies' next earnings date is estimated for Tuesday, December 1, 2026, based on past reporting schedules.

Conference Call Resources

Victory Square Technologies Q1 2025 Earnings FAQ

Victory Square Technologies (OTCMKTS:VSQTF) reported earnings of -$0.02 per share for Q1 2025. The report was announced on Tuesday, July 8, 2025.

Victory Square Technologies reported revenue of $3.16 million for Q1 2025.

Victory Square Technologies' next earnings date is estimated for Tuesday, December 1, 2026. MarketBeat tracks confirmed and estimated earnings dates for Victory Square Technologies on the company's earnings history page.

Victory Square Technologies Earnings Headlines

Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform
October 8 at 7:30 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/victory-square-announces-us-patent-allowance-for-insu-therapeutics-needle-free-insulin-and-glp-1-delivery-platform-302901712.html
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology
October 8 at 7:30 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/hydreight-highlights-us-patent-allowance-for-insu-therapeutics-needle-free-insulin-and-glp-1-delivery-technology-302902230.html
Federal Reserve Reveals Disturbing New Plan To Control Your Money
A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.tc pixel
October 10 at 1:00 AM  |  Weiss Ratings (Ad)
Victory Square Technologies Ranks No. 2 Among Publicly Traded Companies on The Globe and Mail's 2026 Canada's Top Growing Companies List
October 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/victory-square-technologies-ranks-no-2-among-publicly-traded-companies-on-the-globe-and-mails-2026-canadas-top-growing-companies-list-302899250.html
Victory Square Technologies Inc. (OTCMKTS:VSQTF) Shares Shorted: Short Interest Down 49.1% in September
September 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31063307
Victory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 Million
September 1, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/victory-square-technologies-reports-first-half-2026-revenue-of-53-0-million-and-net-income-of-6-5-million-302866285.html
See More Victory Square Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Victory Square Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Victory Square Technologies and other key companies, straight to your email.

About Victory Square Technologies

Victory Square Technologies (OTCMKTS:VSQTF) is a Canadian venture builder and technology investment company focused on identifying, developing and supporting early-stage businesses. The company has historically invested in and helped build ventures in areas including fintech, health technology, artificial intelligence, gaming, esports, blockchain and digital media.

Rather than operating as a single-product business, Victory Square has used a portfolio model that combines capital, strategic guidance and shared business resources. Its activities may include incubating new companies, supporting technology development, and helping portfolio businesses with commercialization, partnerships and growth. The company has also pursued investments in software and other technology-enabled businesses serving consumers and enterprises.

Victory Square is based in Vancouver, British Columbia, and has focused primarily on opportunities in North America and other international technology markets. The company was founded in the mid-2010s and has been associated with entrepreneur Shafin Tejani, who has served in a leadership role. Its portfolio and strategic priorities can change over time as investments are developed, monetized or replaced.

View Victory Square Technologies Profile
Earnings Tools